Mirae Asset Global Investments Co. Ltd. Has $2.10 Million Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Mirae Asset Global Investments Co. Ltd. raised its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 27.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,749 shares of the medical device company’s stock after buying an additional 4,916 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Cooper Companies were worth $2,097,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Cetera Investment Advisers increased its stake in shares of Cooper Companies by 6.3% in the second quarter. Cetera Investment Advisers now owns 22,244 shares of the medical device company’s stock valued at $1,942,000 after buying an additional 1,309 shares during the period. Atomi Financial Group Inc. acquired a new position in Cooper Companies in the 3rd quarter valued at approximately $270,000. CWM LLC increased its position in Cooper Companies by 35.8% in the 3rd quarter. CWM LLC now owns 5,193 shares of the medical device company’s stock valued at $573,000 after acquiring an additional 1,370 shares during the period. Wedmont Private Capital raised its stake in shares of Cooper Companies by 10.7% during the third quarter. Wedmont Private Capital now owns 4,178 shares of the medical device company’s stock valued at $441,000 after acquiring an additional 404 shares during the last quarter. Finally, UMB Bank n.a. lifted its holdings in shares of Cooper Companies by 2,768.2% during the third quarter. UMB Bank n.a. now owns 631 shares of the medical device company’s stock worth $70,000 after purchasing an additional 609 shares during the period. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 1.8 %

COO opened at $93.57 on Monday. The company has a fifty day moving average price of $94.99 and a two-hundred day moving average price of $99.85. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The company has a market cap of $18.67 billion, a P/E ratio of 47.98, a price-to-earnings-growth ratio of 2.41 and a beta of 1.00. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm’s revenue was up 9.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.87 EPS. Analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on COO shares. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Morgan Stanley decreased their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Wells Fargo & Company increased their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Finally, Citigroup dropped their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.